Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rodeghiero

Showing results (171-180 of 266) with videos related to

Pageof 27
Sort By:
Haematologica|January 4, 1998
Pilot study on the safety and efficacy of desmopressin for the treatment or prevention of bleeding in patients with hematologic malignanciesG Castaman, E D Bona, C Schiavotto, et al.
Thrombosis and Haemostasis|February 1, 1993
The genetic defect of type I von Willebrand disease "Vicenza" is linked to the von Willebrand factor geneA M Randi, E Sacchi, G C Castaman, et al.
Journal of Thrombosis and Haemostasis : JTH|January 20, 2006
Factor VIII and von Willebrand factor changes after desmopressin and during pregnancy in type 2M von Willebrand disease Vicenza: a prospective study comparing patients with single (R1205H) and double (R1205H-M740I) defectG Castaman, A B Federici, M Bernardi, et al.
Journal of Clinical Epidemiology|November 1, 1994
Epidemiology of hemophilia and of HIV infection in Italy. GICC. Gruppo Italiano Coagulopatie CongeniteA Ghirardini, N Schinaia, F Chiarotti, et al.
Journal of Thrombosis and Haemostasis : JTH|December 15, 2010
Effect of the VWF promoter (GT)n repeat and single-nucleotide polymorphism c.-2527G>A on circulating von Willebrand factor levels under normal conditionsN Hickson, D Hampshire, G Castaman, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 11, 2006
Laboratory issues in bleeding disordersD Lillicrap, S C Nair, A Srivastava, et al.
Blut|August 1, 1989
Clinical significance of fibrinopeptide A in acute lymphocytic and non-lymphocytic leukaemiaF Rodeghiero, G Castaman, G Soffiati, et al.
Human Molecular Genetics|July 1, 1994
Topologically equivalent mutations causing dysfunctional coagulation factors VII (294Ala-->Val) and X (334Ser-->Pro)F Bernardi, G Castaman, R Redaelli, et al.
European Journal of Haematology|February 1, 1988
Hyper-responsiveness to DDAVP for patients with type I von Willebrand's disease and normal intra-platelet von Willebrand factorF Rodeghiero, G Castaman, E Di Bona, et al.
The New England Journal of Medicine|April 27, 1995
Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosisS Cortelazzo, G Finazzi, M Ruggeri, et al.
Pageof 27

Showing results (171-180 of 266) with videos related to

Sort By:
Pageof 27
Haematologica|January 4, 1998
Pilot study on the safety and efficacy of desmopressin for the treatment or prevention of bleeding in patients with hematologic malignanciesG Castaman, E D Bona, C Schiavotto, et al.
Thrombosis and Haemostasis|February 1, 1993
The genetic defect of type I von Willebrand disease "Vicenza" is linked to the von Willebrand factor geneA M Randi, E Sacchi, G C Castaman, et al.
Journal of Thrombosis and Haemostasis : JTH|January 20, 2006
Factor VIII and von Willebrand factor changes after desmopressin and during pregnancy in type 2M von Willebrand disease Vicenza: a prospective study comparing patients with single (R1205H) and double (R1205H-M740I) defectG Castaman, A B Federici, M Bernardi, et al.
Journal of Clinical Epidemiology|November 1, 1994
Epidemiology of hemophilia and of HIV infection in Italy. GICC. Gruppo Italiano Coagulopatie CongeniteA Ghirardini, N Schinaia, F Chiarotti, et al.
Journal of Thrombosis and Haemostasis : JTH|December 15, 2010
Effect of the VWF promoter (GT)n repeat and single-nucleotide polymorphism c.-2527G>A on circulating von Willebrand factor levels under normal conditionsN Hickson, D Hampshire, G Castaman, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 11, 2006
Laboratory issues in bleeding disordersD Lillicrap, S C Nair, A Srivastava, et al.
Blut|August 1, 1989
Clinical significance of fibrinopeptide A in acute lymphocytic and non-lymphocytic leukaemiaF Rodeghiero, G Castaman, G Soffiati, et al.
Human Molecular Genetics|July 1, 1994
Topologically equivalent mutations causing dysfunctional coagulation factors VII (294Ala-->Val) and X (334Ser-->Pro)F Bernardi, G Castaman, R Redaelli, et al.
European Journal of Haematology|February 1, 1988
Hyper-responsiveness to DDAVP for patients with type I von Willebrand's disease and normal intra-platelet von Willebrand factorF Rodeghiero, G Castaman, E Di Bona, et al.
The New England Journal of Medicine|April 27, 1995
Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosisS Cortelazzo, G Finazzi, M Ruggeri, et al.
Pageof 27